ChromaDex Announces Agreement to Launch Commercial Joint Venture in Mainland China
Press release content from Business Wire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Rob Fried. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Business Wire. The AP news staff was not involved in its creation.
ChromaDex Corporation (NASDAQ:NASDAQ:CDXC) Q1 2022 Earnings Conference Call May 12, 2022, 4:30 PM ET Company Participants Rob Fried – Chief Executive Officer Kevin Farr – Chief Financial...
09.03.2022 - ChromaDex Corp. (NASDAQ:CDXC) today announced fourth quarter and fiscal year 2021 financial results. Fourth Quarter 2021 and Recent Highlights Total net sales were $17.8 million, up 15% year over year. Tru Niagen net sales were $14.1 million, a 14% ...
Total net sales of $67.4 million for the full year, up 14% from the prior year, with $56.7 million from Tru Niagen® and gross margin of 61.5%. Total net sales of $17.8 million for the three months ended December 31, 2021, up 15% from the prior year quarter.LOS ANGELES--(BUSINESS WIRE)--$CDXC #earnings--ChromaDex Cor...
UpdatedWed, Dec 30, 2020 at 8:54 pm ET Replies(27) Ten months after Rob Fried was infected with the coronavirus, he spit up blood and a doctor found his lungs were damaged. (Rob Fried) GREAT NECK, NY — Rob Fried is a healthy 59-year-old. The Great Neck resident runs marathons, often winning medals for his age group. But something happened during a race in early December that was a first for the long-time runner: he finished a half-marathon spitting up blood. Fried had an idea what it was — an after-effect of the coronavirus, which he contracted in February. It left him with perplexing and...